Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity

Vaccine

Volumn 31, Issue 14, 2013, Pages 1838-1847

  Chen, Caiwei ^a,b   Li, Jing ^a   Bi, Yuhai ^a   Yang, Limin ^a   Meng, Shanshan ^a   Zhou, Yuancheng ^a   Jia, Xiaojuan ^a   Meng, Songdong ^a   Sun, Lei ^a   Liu, Wenjun ^a,b  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

B cell epitope; Gp96; HP PRRSV; Humoral and cell mediated immunity; Synthetic peptide vaccine; T cell epitope

Indexed keywords

B CELL EPITOPE; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN GP 96; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; PEPTIDE VACCINE; T CELL EPITOPE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIVIRUS; ARTICLE; BIOINFORMATICS; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PIGLET; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PRIORITY JOURNAL; TH1 CELL; VIREMIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HEAT-SHOCK PROTEINS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MEMBRANE GLYCOPROTEINS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUS SCROFA; SWINE; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84875242812     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.049     Document Type: Article

References (48)

1. Benfield D.A., Nelson E., Collins J.E., Harris L., Goyal S.M., Robison D., et al. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet Diagn Invest 1992, 4(2):127-133.
2. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Wang C., et al. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS ONE 2007, 2(6):pe526.
3. Holtkamp D, Kliebenstein J. PRRS Costs Industry $664 Million Annually. Pork Checkoff Study, http://www.pork.org/News/1265/PRRSCostsIndustry664Millionaspx.2011.
4. Jiang Y., Xiao S., Fang L., Yu X., Song Y., Niu C., et al. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 2006, 24(15):2869-2879.
5. Zheng Q., Chen D., Li P., Bi Z., Cao R., Zhou B., et al. Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Genes 2007, 35(3):585-595.
6. Li J., Jiang P., Li Y., Wang X., Cao J., Zeshan B. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs. Vaccine 2009, 27(6):825-832.
7. Wang X., Li J., Jiang P., Li Y., Zeshan B., Cao J. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge. Virus Res 2009, 143(1):24-32.
8. Cao J., Wang X., Du Y., Li Y., Jiang P. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine. Vaccine 2010, 28(47):7514-7522.
9. Ellingson J.S., Wang Y., Layton S., Ciacci-Zanella J., Roof M.B., Faaberg K.S. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine 2010, 28(14):2679-2686.
10. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27(28):3788-3799.
11. Ostrowski M., Jar J.A.G.A.M., Platt K.B., Osorio F.A., Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 2002, 76(9):4241-4250.
12. Meulenberg J.J., van Nieuwstadt A.P., van Essen-Zandbergen A., Langeveld J.P. Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus. J Virol 1997, 71(8):6061-6067.
13. Costers S., Vanhee M., Van Breedam W., Van Doorsselaere J., Geldhof M., Nauwynck H.J. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution. Virus Res 2010, 154(1-2):104-113.
14. Vashisht K., Goldberg T., Husmann R., Schnitzlein W., Zuckermann F. Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus. Vaccine 2008, 26(36):4747-4753.
15. Díaz I., Pujols J., Ganges L., Gimeno M., Darwich L., Domingo M., et al. In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus. Vaccine 2009, 27(41):5603-5611.
16. Mateu E., Diaz I. The challenge of PRRS immunology. Vet J 2008, 177(3):345-351.
17. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 309(1):18-31.
18. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol 2007, 123(1-3):69-85.
19. Linghua Z., Xingshan T., Yong G., Fengzhen Z. Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine 2006, 24(11):1874-1879.
20. Li H.T., Yan J.B., Li J., Zhou M.H., Zhu X.D., Zhang Y.X., et al. Enhancement of humoral immune responses to HBsAg by heat shock protein Gp96 and its N-terminal fragment in mice. World J Gastroenterol 2005, 11(19):2858-2863.
21. Bolhassani A., Zahedifard F., Taghikhani M., Rafati S. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies. Vaccine 2008, 26(26):3362-3370.
22. Liu Z., Li X., Qiu L., Zhang X., Chen L., Cao S., et al. Treg suppress CTL responses upon immunization with HSP Gp96. Eur J Immunol 2009, 39(11):3110-3120.
23. Li Y., Song H., Li J., Wang Y., Yan X., Zhao B., et al. Hansenula polymorpha expressed heat shock protein Gp96 exerts potent T cell activation activity as an adjuvant. J Biotechnol 2011, 151(4):343-349.
24. Lee C., Calvert J.G., Welch S.K., Yoo D. A DNA-launched reverse genetics system for porcine reproductive and respiratory syndrome virus reveals that homodimerization of the nucleocapsid protein is essential for virus infectivity. Virology 2005, 331(1):47-62.
25. Chen C., Li J., Bi Y., Jia X., Meng S., Sun L., et al. Gp96 enhances the immunogenicity of subunit vaccine of porcine reproductive and respiratory syndrome virus. Virus Res 2012, 167(2):162-172.
26. Dea S., Bilodeau R., Sauvageau R., Martineau G.P. Outbreaks in Quebec pig farms of respiratory and reproductive problems associated with encephalomyocarditis virus. J Vet Diagn Invest 1991, 3(4):275-282.
27. Franke E.D., Hoffman S.L., Sacci J.B., Wang R., Charoenvit Y., Appella E., et al. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. Vaccine 1999, 17(9-10):1201-1205.
28. Strohmaier K., Franze R., Adam K.H. Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 1982, 59(Pt 2):295-306.
29. Muderspach L., Wilczynski S., Roman L., Bade L., Felix J., Small L.A., et al. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res 2000, 6(9):3406-3416.
30. Spearman P., Kalams S., Elizaga M., Metch B., Chiu Y.L., Allen M., et al. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. Vaccine 2009, 27(2):243-249.
31. Li S., Peng L., Zhao W., Zhong H., Zhang F., Yan Z., et al. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses. Vaccine 2011, 29(20):3695-3702.
32. Delputte P.L., Meerts P., Costers S., Nauwynck H.J. Effect of virus-specific antibodies on attachment: internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Vet Immunol Immunopathol 2004, 102(3):179-188.
33. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vaccine Immunol 2007, 14(3):269-275.
34. Bautista, F E.M., Molitor T.W. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Viral Immunol 1997, 10(2):83-94.
35. Lopez Fuertes L., Domenech N., Alvarez B., Ezquerra A., Dominguez J., Castro J.M., et al. Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Res 1999, 64(1):33-42.
36. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. J Gen Virol 2005, 86(7):1943-1951.
37. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 2006, 351(2):249-259.
38. high cells. Vet Res 2009, 40(5):46.
39. Carter Q.L., Curiel R.E. Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection. Vet Immunol Immunopathol 2005, 107(1-2):105-118.
40. Rompato G., Ling E., Chen Z., Van Kruiningen H., Garmendia A.E. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine. Vet Immunol Immunopathol 2006, 109(1-2):151-160.
41. Charerntantanakul W. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Vet Immunol Immunopathol 2009, 129(1-2):1-13.
42. Gong X., Gai W., Xu J., Zhou W., Tien P. Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24. Clin Vaccine Immunol 2009, 16(11):1595-1600.
43. Yan J., Liu X., Wang Y., Jiang X., Liu H., Wang M., et al. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of Gp96. J Gene Med 2007, 9(2):107-121.
44. Warger T., Hilf N., Rechtsteiner G., Haselmayer P., Carrick D.M., Jonuleit H., et al. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 2006, 281(32):22545-22553.
45. Zhang Y., Zan Y., Shan M., Liu C., Shi M., Li W., et al. Effects of heat shock protein Gp96 on human dendritic cell maturation and CTL expansion. Biochem Biophys Res Commun 2006, 344(2):581-587.
46. Ding Y., Qin L., Zamarin D., Kotenko S.V., Pestka S., Moore K.W., et al. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 2001, 167(12):6884-6892.
47. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180(9):5771-5777.
48. Zhou L., Zhang J., Zeng J., Yin S., Li Y., Zheng L., et al. The 30-amino-acid deletion in the Nsp2 of highly pathogenic porcine reproductive and respiratory syndrome virus emerging in China is not related to its virulence. J Virol 2009, 83(10):5156-5167.